Venture Partner at Catalio Capital Management
View Live Interactive Profile →Catalio Capital Management lists David Sinclair as a Venture Partner. The firm's profile page gives the current affiliation as Co-Director, Paul F. Glenn Labs for the Biology of Aging and Professor of Genetics, Harvard Medical School. His stated honours include inclusion in Time Magazine's 100 (2014), an NIH Director's Pioneer Award (2017) and appointment as an Officer of the Order of Australia (2018).